Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Low platelets… but the marrow is fighting back?
Think: Immature Platelet Fraction (IPF)
In hematology, the Immature Platelet Fraction (IPF) measures the percentage of newly released, RNA-rich platelets circulating in the blood.
These young platelets are the platelet equivalent of reticulocytes in anemia — giving us a real-time glimpse into marrow platelet production.
Why is IPF important?
Thrombocytopenia generally happens through two major mechanisms:
- Decreased platelet production: Bone marrow is not producing enough platelets.
- Increased platelet destruction or consumption: Platelets are being destroyed, consumed, or lost faster than normal.
This is where IPF becomes clinically useful:
High IPF suggests active marrow response and increased platelet production.
Often seen in:
- Immune thrombocytopenia (ITP)
- Peripheral platelet destruction
- Consumptive processes
- Recovery after marrow suppression or chemotherapy
Low or normal IPF may suggest impaired marrow production
Such as:
- Aplastic anemia
- Marrow infiltration
- Chemotherapy-related suppression
In practice, IPF helps answer an important clinical question:
- Is the marrow failing to produce platelets… or
- Is the body destroying and consuming them peripherally?
But IPF should never be interpreted alone.
A proper thrombocytopenia workup still begins with:
- CBC
- Peripheral smear review
- Excluding pseudothrombocytopenia from platelet clumping.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
-
Oct 5, 2026, 12:29Mirvat Alasnag: Creating a Space for Women in Cardiovascular Medicine
-
Oct 5, 2026, 11:59Khaoula Mazouzi: The Potential of Haemoglobin Vesicles as an Oxygen Carrier
-
Oct 5, 2026, 11:56Muhammet Özbilen: What Does New Evidence Tell Us About IV Iron in Pregnancy?